All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-C298 | Human anti-EBNA4 T cell receptor (CB-C038), pCDTCR1 | EBV | CB-C038 | Human | IVTDFSVIK | HLA-A*011 | Lentiviral vector | |
TCR-C299 | Human anti-EBNA4 T cell receptor (CB-C039), pCDTCR1 | EBV | CB-C039 | Human | IVTDFSVIK | HLA-A*011 | Lentiviral vector | |
TCR-C300 | Human anti-EBNA4 T cell receptor (CB-C040), pCDTCR1 | EBV | CB-C040 | Human | AVFDRKSDAK | HLA-A*011 | Lentiviral vector | |
TCR-C301 | Human anti-EBNA4 T cell receptor (CB-C041), pCDTCR1 | EBV | CB-C041 | Human | AVFDRKSDAK | HLA-A*011 | Lentiviral vector | |
TCR-C302 | Human anti-EBNA4 T cell receptor (CB-C042), pCDTCR1 | EBV | CB-C042 | Human | IVTDFSVIK | HLA-A*011 | Lentiviral vector | |
TCR-C303 | Human anti-EBNA4 T cell receptor (CB-C043), pCDTCR1 | EBV | CB-C043 | Human | IVTDFSVIK | HLA-A*011 | Lentiviral vector | |
TCR-C304 | Human anti-EBNA4 T cell receptor (CB-C044), pCDTCR1 | EBV | CB-C044 | Human | IVTDFSVIK | HLA-A*011 | Lentiviral vector | |
TCR-C305 | Human anti-EBNA4 T cell receptor (CB-C045), pCDTCR1 | EBV | CB-C045 | Human | IVTDFSVIK | HLA-A*011 | Lentiviral vector | |
TCR-C306 | Human anti-EBNA4 T cell receptor (CB-C046), pCDTCR1 | EBV | CB-C046 | Human | IVTDFSVIK | HLA-A*011 | Lentiviral vector | |
TCR-C307 | Human anti-EBNA4 T cell receptor (CB-C047), pCDTCR1 | EBV | CB-C047 | Human | IVTDFSVIK | HLA-A*011 | Lentiviral vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION